Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial
| Image |  |
|---|---|
| Description | scientific article published on December 1, 2011 |
| Author/s |
author: Bradley J. Monk |
| Publication date | December 1, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |